Valeo Financial Advisors, LLC Seelos Therapeutics, Inc. Transaction History

Valeo Financial Advisors, LLC

  • $3.81 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 19, 2023
SELL
$0.16 - $1.64 $55 - $570
-348 Reduced 2.29%
14,825 $2,000
Q4 2022

Feb 09, 2023
BUY
$0.66 - $259.46 $229 - $90,292
348 Added 2.35%
15,173 $10,000
Q2 2022

Aug 03, 2022
BUY
$0.51 - $0.93 $7,560 - $13,787
14,825 New
14,825 $10,000
Q2 2021

Jul 22, 2021
SELL
$2.64 - $6.32 $7,920 - $18,960
-3,000 Closed
0 $0
Q1 2021

Apr 12, 2021
BUY
$1.35 - $4.99 $4,050 - $14,970
3,000 New
3,000 $15,000

Others Institutions Holding SEEL

# of Institutions
1
Shares Held
40.5K
Call Options Held
0
Put Options Held
0
View Full List

About SEELOS THERAPEUTICS, INC.

SEEL Quotes by TradingView
  • Ticker SEEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 106,691,000
  • Market Cap $117M
  • Description
  • Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...
More about SEEL
Track This Portfolio

Track Valeo Financial Advisors, LLC Portfolio

Follow Valeo Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Valeo Financial Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email